跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-CIDOFOVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-CIDOFOVIR
Authorized
STANDARD
MAR-CIDOFOVIR
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
33ba2b6b997dd30f
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
33ba2b6b997dd30f
Drug Approval Canada Name
MAR-CIDOFOVIR
Product Name
MAR-CIDOFOVIR
Status
Marketed
Status Date
2018-07-11
Original Market Date
2018-07-11
Din
02473925
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:18.32
Atc Original
J05AB12 CIDOFOVIR
Atc Name
j 05 ab 12
Aig Number
0137821001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
CIDOFOVIR (CIDOFOVIR DIHYDRATE)
375 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
33ba2b6b997dd30f
Type
Standard
Back to Health Canada Approvals